Impact of biologics on growth in children with juvenile idiopathic arthritis

by Uettwiller, F, Pinto, G, Polak, M, Quartier, P
Published 2011

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis

by Woerner, A, Uettwiller, F, Melki, I, Bader-Meunier, B, Mouy, R, Wouters, C, Quartier, P
Published 2013

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent

by Woerner, A, Uettwiller, F, Melki, I, Mouy, R, Wouters, C, Bader-Meunier, B, Quartier, P
Published 2015

Identification of three ADA2 deficiency families with novel CECR1 mutations

by Sarrabay, G, Insalaco, A, Uettwiller, F, Tieulié, N, Quartier-dit-maire, P, Melki, J, Touitou, I
Published 2015

ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters

by Uettwiller, F, Sarrabay, G, Rodero, M P, Rice, G I, Lagrue, E, Marot, Y, Deiva, K, Touitou, I, Crow, Y J, Quartier, P
Published 2016